Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 12,150 Cr.
- Current Price ₹ 1,196
- High / Low ₹ 1,610 / 1,009
- Stock P/E 42.5
- Book Value ₹ 162
- Dividend Yield 0.29 %
- ROCE 17.4 %
- ROE 15.9 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 22.8% of last 10 years
Cons
- Stock is trading at 7.42 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare BSE 1000 Nifty 500 BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 | 234 | 321 | 402 | 543 | 719 | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,703 | 1,820 | |
| 128 | 204 | 266 | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1,022 | 1,155 | 1,245 | |
| Operating Profit | 41 | 30 | 55 | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 548 | 575 |
| OPM % | 24% | 13% | 17% | 17% | 28% | 28% | 25% | 32% | 34% | 33% | 33% | 32% | 32% |
| 10 | 16 | 11 | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 42 | 35 | |
| Interest | 3 | 3 | 3 | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 82 | 81 |
| Depreciation | 9 | 18 | 22 | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 151 | 159 |
| Profit before tax | 38 | 24 | 41 | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 358 | 371 |
| Tax % | 35% | 28% | 24% | 22% | 22% | 41% | 29% | 26% | 25% | 26% | 26% | 21% | |
| 25 | 17 | 31 | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 282 | 290 | |
| EPS in Rs | 3.34 | 2.28 | 4.23 | 4.13 | 5.07 | 6.34 | 4.55 | 14.70 | 20.77 | 21.38 | 23.97 | 27.40 | 28.10 |
| Dividend Payout % | 7% | 11% | 7% | 12% | 10% | 16% | 0% | 14% | 14% | 14% | 13% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 13% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 44% |
| 3 Years: | 6% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 17% |
| Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 166 | 275 | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1,157 | 1,367 | 1,547 |
| 22 | 24 | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 891 | |
| 34 | 41 | 55 | 73 | 89 | 123 | 116 | 112 | 140 | 146 | 145 | 236 | |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
| 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 | 1,756 | |
| CWIP | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 79 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 404 |
| 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 759 | 590 | 380 | 535 | |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 329 | 321 | 396 | 420 | |
| -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | -259 | |
| -7 | 93 | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | -147 | |
| Net Cash Flow | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 7 | -7 | 10 | 14 |
| Free Cash Flow | -35 | -46 | -21 | -103 | 42 | 96 | 67 | 162 | 188 | -32 | 250 | 204 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 95% | 88% | 79% | 88% | 94% | 95% | 102% | 93% | 103% | 95% | 97% | 95% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 10 | 16 | 14 | 24 | 22 | 25 | 15 | 16 | 20 | 19 | 22 |
| Inventory Days | 39 | 35 | 48 | 36 | 32 | 55 | 36 | 28 | 43 | 53 | 52 | 67 |
| Days Payable | 121 | 107 | 142 | 151 | 197 | 202 | 190 | 121 | 182 | 180 | 170 | 162 |
| Cash Conversion Cycle | -72 | -62 | -79 | -100 | -141 | -124 | -130 | -78 | -123 | -107 | -100 | -73 |
| Working Capital Days | -35 | -36 | -28 | -31 | -26 | -18 | -17 | -16 | 73 | 43 | 19 | 8 |
| ROCE % | 22% | 11% | 14% | 14% | 16% | 16% | 11% | 23% | 24% | 19% | 19% | 17% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| ALOS days |
|
|||||||
| Capacity Beds count |
||||||||
| IP Discharges count |
||||||||
| Occupancy % |
||||||||
| OP Consultations count |
||||||||
| ARPOB INR per day |
||||||||
| Deliveries count |
||||||||
| Operational Beds count |
||||||||
| Number of Hospitals count |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Compliance certificate under Regulation 74(5) for quarter ended September 30, 2026 filed.
-
Intimation Of Execution Of Lease Agreement With APCRDA For Development Of A Children'S Hospital At Amravati, Andhra Pradesh.
- Rainbow signed 60-year lease for 2 acres in Amaravati to develop a 250-bed children’s hospital and perinatal facility.
-
Announcement under Regulation 30 (LODR)-Credit Rating
- ICRA reaffirmed Rainbow Children’s Medicare’s issuer rating at [ICRA] AA (Stable) on September 29, 2026.
-
Closure of Trading Window
- Trading window closes October 1, 2026; reopens 48 hours after Q2 FY27 results.
-
Board Meeting Outcome for Outcome Of Board Meeting
- Board appointed Sudarshan Patodia as CFO and Group CFO effective September 23, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022PPT
-
Jun 2022Transcript PPT
Business Overview:[1]
The company operates 24 hospitals
and 5 clinics across 9 cities, with a total
bed capacity of 2,565. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."